Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic PreConditioning (RIPC) in Lymphoma patients receiving anthracyclines.
None
Any cancer who received anthracyclines treatment before the index episode.
Previous clinical diagnosis of heart failure.
Permanent atrial fibrillation (AF).
Severe valvular or sub-valvular heart disease.
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Lead sponsor
European Commission
Collaborator